UPDATE : Monday, September 7, 2020
상단여백
Takeda to develop cancer therapy inhibitor
Takeda Pharmaceuticals has made an exclusive licensing agreement with Tesar...
by Constance Williams  |  2017-08-08 15:56
라인
Korea approves phase 3 trials of Lilly’s Alzheimer’s therapy
The Ministry of Food and Drug Safety has approved the extended phase 3 clin...
by Lee Hye-seon  |  2017-08-08 15:10
라인
Korean firms challenge Champix’s dominance in antismoking aid market
Domestic pharmaceutical companies are continuing to challenge Pfizer’s smok...
by Lee Hye-seon  |  2017-08-07 17:47
라인
Regulators to add condition for approving chronic hepatitis B therapy
The Ministry of Food and Drug Safety will add the result of analyzing child...
by Lee Hye-seon  |  2017-08-07 17:42
라인
Daehwa Pharm to use Medidata’s data management solutions
Daehwa Pharmaceuticals will use Medidata’s data management solutions to con...
by Marian Chu  |  2017-08-07 16:39
라인
New osteoporosis therapy causes curiosity about drug price
Ten years have passed since Amgen’s “Prolia,” the so-called first biologica...
by Park Gi-taek  |  2017-08-07 14:42
라인
Handok expands gene testing analysis to children
Handok has expanded its genome testing service to children, the company sai...
by Marian Chu  |  2017-08-07 11:06
라인
Clearer standards for relief of harms from drugs’ side effects
The standards for medical products excluded from the application for the re...
by Lee Hye-seon  |  2017-08-04 18:30
라인
Cosmetics firm acquires external preparations maker
Cosmetics company Tonymoly has bought a 47.6-percent stake of Tai Guk Pharm...
by Lee Hye-seon  |  2017-08-03 16:18
라인
Yungjin’s new drug completes phase 2a clinical trial in US
Yungjin Pharmaceutical has secured the safety of “YPL-001,” a new drug to t...
by Lee Hye-seon  |  2017-08-03 15:42
라인
Phase 3 clinical trials for new schizophrenia drug
Bukwang Pharmaceutical will enter into phase 3 clinical trials of Lurasidon...
by Lee Hye-seon  |  2017-08-03 14:53
라인
FDA approves Imbruvica treat chronic GVHD
The U.S. Food and Drug Administration (FDA) Wednesday expanded the approval...
by Constance Williams  |  2017-08-03 10:32
라인
Pharmaceuticals stage fierce competition over composite drugs
Korean pharmaceutical companies are focusing their attention on the develop...
by Lee Hye-seon  |  2017-08-02 17:01
라인
Celgene’s leukemia drug wins FDA approval
The U.S. Food and Drug Administration Tuesday approved Idhifa (compound: en...
by Constance Williams  |  2017-08-02 10:31
라인
MSD gets approval to expand Januvia label
MSD Korea said Tuesday that its Januvia (ingredient name: Citigliptin), Jan...
by Constance Williams  |  2017-08-01 17:37
라인
Regulators to add liver damage risks to antiobestic drug
Antiobestic drug Contrav ER Tab. (compound: naltrexon/bupropion), imported ...
by Lee Hye-seon  |  2017-08-01 17:21
라인
LG’s development of composite drug gains momentum
The development of the ‘Gemigliptin+Rosuvastatin’ complex developed by LG C...
by Lee Hye-seon  |  2017-08-01 15:24
라인
Lilly’s Lartruvo to hit domestic market
Lilly Korea said Tuesday it would release an advanced soft tissue sarcoma t...
by Constance Williams  |  2017-08-01 14:03
라인
Takeda gets approval for multiple myeloma drug
Takeda Pharmaceuticals Korea한국다케다제약 said its Ninlarco (ingredient name: ixa...
by Constance Williams  |  2017-08-01 10:47
라인
Stress management crucial for operation-room nurses
A bill has been proposed to prohibit overtime work by doctors and nurses to...
by Nam Doo-hyun  |  2017-07-31 17:20
-이전111112113114115116117118119120-
176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
여백
Most viewed
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top